ME1 Effect of Medicare Part D on Drug Utilization, Drug Expenditures, and Health Care Spending in Patients With Chronic Pulmonary Obstructive Disease

Value in Health - United Kingdom
doi 10.1016/j.jval.2012.03.017
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Health Care Utilization in Chronic Obstructive Pulmonary Disease

Archives of Internal Medicine
2000English

Prescription Drug Advertising and Drug Utilization: The Role of Medicare Part D

2015English

The Response of Drug Expenditures to Non-Linear Contract Design: Evidence From Medicare Part D

2013English

Radiation Oncology Drug Prescription Patterns in Medicare Part D

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

The Effect of Medicare Part D on Pharmaceutical Prices and Utilization

American Economic Review
EconomicsEconometrics
2010English

Exacerbations, Health Resource Utilization, and Costs Among Medicare Beneficiaries With Chronic Obstructive Pulmonary Disease Treated With Nebulized Arformoterol Following a Respiratory Event

Chronic Obstructive Pulmonary Diseases
PulmonaryRespiratory Medicine
2019English

Рhysiotherapy in Patients With Chronic Obstructive Pulmonary Disease

Open Access Macedonian Journal of Medical Sciences
Medicine
2017English

Effect of Respiratory Rate on Respiratory Patterns in Patients With Chronic Obstructive Pulmonary Disease.

Internal Medicine
Internal MedicineMedicine
1997English

Opioid Drug Use in Emergency and Adverse Outcomes Among Patients With Chronic Obstructive Pulmonary Disease: A Multicenter Observational Study

Scientific Reports
Multidisciplinary
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy